Setterwalls has together with Latham & Watkins LLP assisted Vivalto Santé in connection with an exclusivity commitment regarding the acquisition of the French business of Capio AB (publ).
Vivalto Santé has entered into exclusivity with Capio regarding the sale of Capio France pending finalization of the documentation related thereto as is customary on the French market. The consideration for the proposed transaction would be an upfront enterprise value of approximately SEK 4.6 billion (EUR 425 million) plus an earn-out contingent on 2018 financial performance, up to a total enterprise value of approximately SEK 4.9 billion (EUR 455 million). The completion of the transaction is subject to certain conditions, including the approval of the shareholders of Capio AB (publ) at an extraordinary general meeting in accordance with the Swedish Takeover Rules. Vivalto Santé is a leading French healthcare provider employing around 5,400 employees. For further information about the acquisition and Vivalto Santé, please refer to the company’s website: www.vivalto-sante.com.